[Pyr3]-Amyloid ß-Protein (Human, 3-42) (0.5 mg vial)

Product overview
Catalog Number
PPH08-0860
Sequence
Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
Target
Major Neuritic Plaque Component in Alzheimer's Disease
Description
[Pyr3]-Beta-Amyloid-Protein (3-42) was found to be the predominant amyloid Beta-peptide structure deposited in human brain of Alzheimer's disease and Down's syndrome patients. Therefore, [Pyr3]-Beta-Amyloid-Protein (3-42) is suggested to accumulate in the brain and to trigger the formation of insoluble amyloid Beta-peptide deposits. Nussbaum et al. studies the Prion-like behavior and tau-dependent cytotoxicity of the truncated A-Beta sequence. 183449-57-2. C196H299N53O55S. MW: 4309.97
Category
Catalog peptides, Biologically Active Peptides
Product Properties
Quantity

1mg
Storage

Shipped at 4°C. Store at -20°C for one year.
Purity

> 95%
Source

Synthetic
Forma appearance

Lyophilized powder
Price

€366,00
  • For research use only
  • Not for use in diagnostic procedures

€366,00 Tax excluded
Contact us to request price here
Register to buy peptides
Contact us